Advertisement

Pharmaceutical Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Most Read

  1. GSK’s belantamab mafodotin performs well in refractory multiple myeloma
  2. Medidata CEO Tarek Sherif on the past and future of pharma R&D
  3. AstraZeneca’s Imfinzi fails to meet endpoint in Stage IV NSCLC
  4. AstraZeneca’s diabetes drug Farxiga performs well in heart failure patients
  5. FDA approves first non-controlled substance narcolepsy drug

Latest Content

Avoiding pricy clinical research delays

A vast majority of clinical trials face postponements, costing precious time and money and impacting patients, which why managing time, resources and participants are crucial in avoiding delays and providing results.

Medidata CEO Tarek Sherif on the past and future of pharma R&D

This year marks Medidata’s 20th anniversary; it is the also the year it will be acquired by Dassault. The company’s CEO and co-founder Tarek Sherif reflects on how the clinical development space has evolved in the past two decades and predicts the main drivers of the industry’s future transformation.

Latest News

Read our magazine

Pharma Technology Focus is the essential reading material for decision-makers in the pharmaceutical industry, bringing you the latest news and analysis in an exciting, interactive format.

Send me notifications of new editions:

Close
Close
Close

Go Top